ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41009819

Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.

Ji ZZ and 9 others. Int J Mol Sci, 2025. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer. Papers, record 41009819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009819

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-09-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ji ZZZoey Zeyuan
2Chan MKMax Kam-Kwan
3Tang PCPhilip Chiu-Tsunhttps://orcid.org/0000-0002-1768-1127
4Ng CSCalvin Sze-Hanghttps://orcid.org/0000-0002-8074-0900
5Li CChunjie
6Zhang DDongmei
7Nikolic-Paterson DJDavid Jhttps://orcid.org/0000-0001-5734-2931
8To KFKa-Fai
9Jiang XXiaohuahttps://orcid.org/0000-0002-7372-4961
10Tang PMPatrick Ming-Kuenhttps://orcid.org/0000-0002-3194-3736

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Humans
Tumor Microenvironment
Animals
Neurons

Source PubMed

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
C4013-24GF, 24102723, 14107624Research Grants Council of Hong KongPubMed
PDFS2122-4S06, PDFS2425-4S07RGC Postdoctoral Fellowship SchemePubMed
10210726, 11220576Health and Medical Research FundPubMed
ITS/177/22FP, ITS/016/23MS, ITS/301/23Innovation and Technology FundPubMed
PFP202210-004CU Medicine Passion for Perfection SchemePubMed
4620528Faculty Innovation Award 2019PubMed
8423011Peter Hung Pain Research Institute Research FundPubMed
178896941CUHK Strategic Seed Funding for Collaborative Research SchemePubMed
4054844, 2025.142Direct Grant for ResearchPubMed
NL/LT/PDFS2022/0360/22lt, WW/PDFS2023/0640/23en, FPFS/23-24/046Postdoctoral Fellowship SchemePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References265

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137,996,538Eph receptors and ephrins in cancer progression.Nat Rev Cancer2024https://conductscience.org/library/papers/37996538PubMed
223,846,904Autonomic nerve development contributes to prostate cancer progression.Science2013https://conductscience.org/library/papers/23846904PubMed
318,337,008Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.Pain2008https://conductscience.org/library/papers/18337008PubMed
437,712,174Adipose-Derived Mesenchymal Stem Cell-Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37712174PubMed
522,327,623RET, ROS1 and ALK fusions in lung cancer.Nat Med2012https://conductscience.org/library/papers/22327623PubMed
633,334,813Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.Cancer Res2021https://conductscience.org/library/papers/33334813PubMed
734,394,823Methylation of CALCA and CALCB in Pancreatic Ductal Adenocarcinoma.Oxid Med Cell Longev2021https://conductscience.org/library/papers/34394823PubMed
838,956,074Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38956074PubMed
929,666,812Tumor progression: the neuronal input.Ann Transl Med2018https://conductscience.org/library/papers/29666812PubMed
1040,122,998Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells.Cell Res2025https://conductscience.org/library/papers/40122998PubMed

1 to 10 of 265

See all 265 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42,941,861Molecular Targeting of the Peripheral Nerve-Tumor Axis in Extracranial Solid Cancers: Eight Signaling Systems, One Effect-Systematic Review and Multilevel Meta-Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42941861PubMed
42,397,500Neural regulation of cancer: from synaptic integration to neuro-immune regulation.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42397500PubMed
42,123,376Cancer Neoaxonogenesis: Mechanisms and Factors Involved in the Recruitment of Peripheral Nerves by Cancer Tissue.Int J Mol Sci2026https://conductscience.org/library/papers/42123376PubMed
41,930,197The authors respond to feedback on Cancer Cell-Memory Macrophage Hybrid Theory for metastatic cancer cells.Front Oncol2026https://conductscience.org/library/papers/41930197PubMed
41,744,673The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities.Biology (Basel)2026https://conductscience.org/library/papers/41744673PubMed
41,742,871Mutual amplification of sensory nerve outgrowth and tumor progression in myeloma.Haematologica2026https://conductscience.org/library/papers/41742871PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41009819

GET https://conductscience.org/api/papers/v1/41009819/references?page=2

API referenceFor AI assistants